People · Operator
Named in public records as an officer, director or promoter · active 2020–2020 · Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cardiol Therapeutics Inc. | — | Pharma | Seed | $5.9M | $1.8M | 2020 |
Dr. Guillermo R. Torre-Amione at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dr. Guillermo R. Torre-Amione on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Eldon R. Smith | 1 | 3 |
| Bernard Lim | 1 | 2 |
| Eldon Smith | 1 | 2 |
| Andrew Hamer | 1 | 2 |
| Teri Loxam | 1 | 1 |
| Jennifer Chao | 1 | 1 |
| Peter Pekos | 1 | 1 |
| Colin Stott | 1 | 1 |
| Tim Garnett | 1 | 1 |
| Deborah R. Brown | 1 | 1 |
| Colin R. Stott | 1 | 1 |
| Chris R. Waddick | 1 | 1 |
| Peter R. Pekos | 1 | 1 |
| Anthony R. Bolton | 1 | 1 |
| Thomas R. Moffatt | 1 | 1 |
| Iain R. Chalmers | 1 | 1 |
| Terry E. Lynch | 1 | 1 |
| Iain E. Chalmers | 1 | 1 |
| Peter E. Pekos | 1 | 1 |
| Deborah E. Brown | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.